Gallacher Capital Management LLC Has $245,000 Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 5,830,000 shares, a drop of 9.9% from the February 29th total of 6,470,000 shares. Approximately 5.8% of the company’s shares are sold short. Based on an […]
Cantor Fitzgerald restated their overweight rating on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) in a report published on Friday, Benzinga reports. They currently have a $34.00 target price on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on CPRX. TheStreet raised shares of Catalyst Pharmaceuticals from a c+ […]
StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a hold rating to a buy rating in a research note released on Thursday morning. Other research analysts also recently issued reports about the company. Citigroup started coverage on Catalyst Pharmaceuticals in a research report on Thursday, March 14th. They set a buy rating […]